Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

CRL

Charles River Laboratories International, Inc.

Healthcare · USD

Set alert

Price alert · CRL

All alert types
359.41 USD -16.69 -4.44%
As of Oct 30, 2026 Extended hours 365.29 +1.64%
Bid
359.26 × 300
Ask
359.75 × 200
351.98 Day range 374.40
149.93 52-week range 376.10
YTD
+80.17%
1 year
+100.66%
Open
372.99
Prev close
376.10
Mkt cap
17.16B
Vol
1.50M
Avg vol
1.02M
EPS
-4.80
P/E
0.00
Div yield
0.00%
More statistics
Low
351.98
High
374.40
Forward P/E
28.20
Beta
1.40
Short ratio
2.77
Inst. own
122.19%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
300.55
200-d avg
221.07
1y target
318.87

5D chart

Chart tools
Interval
1m5m15m30m
CRL five-day price chart345.9354.3362.8371.2379.6Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

3.03 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 2

Valuation

P/E -70.0×
FY 2016: 23.2×FY 2017: 42.1×FY 2018: 24.0×FY 2019: 29.5×FY 2020: 34.0×FY 2021: 48.5×FY 2022: 22.8×FY 2023: 25.5×FY 2024: 931×FY 2025: -70.0×
FY 2016 5y median 25.5× FY 2025
P/S 2.5×
FY 2016: 2.1×FY 2017: 2.8×FY 2018: 2.4×FY 2019: 2.8×FY 2020: 4.2×FY 2021: 5.4×FY 2022: 2.8×FY 2023: 2.9×FY 2024: 2.4×FY 2025: 2.5×
FY 2016 5y median 2.8× FY 2025
P/B 3.2×
FY 2016: 4.3×FY 2017: 5.0×FY 2018: 4.1×FY 2019: 4.6×FY 2020: 5.9×FY 2021: 7.5×FY 2022: 3.7×FY 2023: 3.4×FY 2024: 2.8×FY 2025: 3.2×
FY 2016 5y median 3.4× FY 2025
P/FCF 19.5×
FY 2016: 14.7×FY 2017: 22.2×FY 2018: 18.0×FY 2019: 21.9×FY 2020: 32.6×FY 2021: 35.6×FY 2022: 37.5×FY 2023: 33.1×FY 2024: 19.1×FY 2025: 19.5×
FY 2016 5y median 33.1× FY 2025
EV/EBITDA 31.5×
FY 2016: 12.5×FY 2017: 13.5×FY 2018: 13.7×FY 2019: 16.4×FY 2020: 18.6×FY 2021: 26.7×FY 2022: 14.1×FY 2023: 14.4×FY 2024: 20.8×FY 2025: 31.5×
FY 2016 5y median 20.8× FY 2025
EV/Sales 3.2×
FY 2016: 2.8×FY 2017: 3.3×FY 2018: 3.1×FY 2019: 3.5×FY 2020: 4.9×FY 2021: 6.2×FY 2022: 3.5×FY 2023: 3.6×FY 2024: 3.0×FY 2025: 3.2×
FY 2016 5y median 3.5× FY 2025
FCF Yield 5.1%
FY 2016: 6.8%FY 2017: 4.5%FY 2018: 5.5%FY 2019: 4.6%FY 2020: 3.1%FY 2021: 2.8%FY 2022: 2.7%FY 2023: 3.0%FY 2024: 5.2%FY 2025: 5.1%
FY 2016 5y median 3.0% FY 2025

Profitability

Gross Margin 30.5%
FY 2016: 38.3%FY 2017: 37.7%FY 2018: 37.1%FY 2019: 36.6%FY 2020: 36.7%FY 2021: 37.7%FY 2022: 36.8%FY 2023: 36.4%FY 2024: 32.9%FY 2025: 30.5%
FY 2016 5y median 36.4% FY 2025
Operating Margin 12.6%
FY 2016: 14.1%FY 2017: 15.5%FY 2018: 14.6%FY 2019: 13.4%FY 2020: 14.8%FY 2021: 16.7%FY 2022: 16.4%FY 2023: 14.9%FY 2024: 5.6%FY 2025: 12.6%
FY 2016 5y median 14.9% FY 2025
Net Margin -3.6%
FY 2016: 9.2%FY 2017: 6.6%FY 2018: 10.0%FY 2019: 9.6%FY 2020: 12.5%FY 2021: 11.0%FY 2022: 12.2%FY 2023: 11.5%FY 2024: 0.3%FY 2025: -3.6%
FY 2016 5y median 11.0% FY 2025
ROE -4.6%
FY 2016: 18.5%FY 2017: 11.8%FY 2018: 17.2%FY 2019: 15.4%FY 2020: 17.2%FY 2021: 15.4%FY 2022: 16.3%FY 2023: 13.2%FY 2024: 0.3%FY 2025: -4.6%
FY 2016 5y median 13.2% FY 2025
ROIC 8.4%
FY 2016: 7.2%FY 2017: 4.9%FY 2018: 8.0%FY 2019: 7.3%FY 2020: 7.5%FY 2021: 8.1%FY 2022: 7.9%FY 2023: 7.1%FY 2024: 0.9%FY 2025: 8.4%
FY 2016 5y median 7.9% FY 2025
ROA -2.0%
FY 2016: 5.7%FY 2017: 4.2%FY 2018: 5.9%FY 2019: 5.4%FY 2020: 6.6%FY 2021: 5.6%FY 2022: 6.4%FY 2023: 5.8%FY 2024: 0.1%FY 2025: -2.0%
FY 2016 5y median 5.6% FY 2025

Growth (YoY)

Revenue -0.9%
FY 2016: 23.3%FY 2017: 10.5%FY 2018: 22.0%FY 2019: 15.7%FY 2020: 11.5%FY 2021: 21.1%FY 2022: 12.3%FY 2023: 3.9%FY 2024: -1.9%FY 2025: -0.9%
FY 2016 FY 2025
Operating Income 123.4%
FY 2016: 15.1%FY 2017: 21.4%FY 2018: 15.0%FY 2019: 6.0%FY 2020: 23.2%FY 2021: 36.3%FY 2022: 10.4%FY 2023: -5.2%FY 2024: -63.2%FY 2025: 123.4%
FY 2016 FY 2025
EPS (diluted) -1555.0%
FY 2016: 3.2%FY 2017: -21.4%FY 2018: 81.9%FY 2019: 9.7%FY 2020: 42.0%FY 2021: 5.6%FY 2022: 24.7%FY 2023: -2.7%FY 2024: -97.8%FY 2025: -1555.0%
FY 2016 FY 2025
Free Cash Flow 3.4%
FY 2016: 8.9%FY 2017: -3.8%FY 2018: 28.8%FY 2019: 13.1%FY 2020: 11.6%FY 2021: 40.0%FY 2022: -44.6%FY 2023: 23.9%FY 2024: 37.3%FY 2025: 3.4%
FY 2016 FY 2025

Financial Health

Current Ratio 1.3×
FY 2016: 1.5×FY 2017: 1.8×FY 2018: 1.6×FY 2019: 1.4×FY 2020: 1.4×FY 2021: 1.2×FY 2022: 1.3×FY 2023: 1.5×FY 2024: 1.4×FY 2025: 1.3×
FY 2016 5y median 1.3× FY 2025
Quick Ratio 1.0×
FY 2016: 1.3×FY 2017: 1.5×FY 2018: 1.4×FY 2019: 1.2×FY 2020: 1.2×FY 2021: 1.0×FY 2022: 1.1×FY 2023: 1.2×FY 2024: 1.1×FY 2025: 1.0×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 1.0×
FY 2016: 1.5×FY 2017: 1.1×FY 2018: 1.3×FY 2019: 1.2×FY 2020: 1.0×FY 2021: 1.3×FY 2022: 1.0×FY 2023: 0.9×FY 2024: 0.8×FY 2025: 1.0×
FY 2016 5y median 1.0× FY 2025
Net Debt / EBITDA 6.9×
FY 2016: 3.0×FY 2017: 2.1×FY 2018: 3.0×FY 2019: 3.2×FY 2020: 2.5×FY 2021: 3.6×FY 2022: 2.9×FY 2023: 2.7×FY 2024: 4.4×FY 2025: 6.9×
FY 2016 5y median 3.6× FY 2025
Interest Coverage 4.7×
FY 2016: 8.6×FY 2017: 9.7×FY 2018: 5.2×FY 2019: 5.8×FY 2020: 5.0×FY 2021: 8.0×FY 2022: 11.0×FY 2023: 4.5×FY 2024: 1.8×FY 2025: 4.7×
FY 2016 5y median 4.7× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-27